“We have not announced the timing of when we plan to re-enter the category, but we do plan on re-entering that category.”

In context

“Salvatore Mancuso (Chief Executive Officer): Yes, sure. So let me start with on!. We believe on! classic and on! PLUS both have a place in our portfolio, and they're both important. If you look at on! classic, it's a smaller pouch. It's more of a dry feel. Currently, it has lower nicotine strengths in the marketplace. So we will continue to innovate when it comes to on! classic. And we believe that on! PLUS plays an important role as well. It has currently higher nicotine strengths. It's a larger pouch and has more of a wet feel. And so they both resonate with consumers, and they both play an important role in our nicotine product portfolio. I talked a lot about e-vapor with Faham. I would say that e-vapor can play an important role in long-term tobacco harm reduction here in the U.S. We intend to participate in that category. But we recognize it's important to have sustained enforcement against the illicit manufacturers who are ignoring and really avoiding the regulatory landscape. So it's important that enforcement occurs, but it's also important that the FDA continues to authorize products so that the adult nicotine consumer has choices to participate in that category and be able to use reduced-risk products. We have not announced the timing of when we plan to re-enter the category, but we do plan on re-entering that category. And when we have more to report, of course, we will.”